HCR Wealth Advisors
- SEC CIK
- 0001697715
- Latest filing
- Jul 13, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by HCR Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 924
- Value
- $278.2K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 924 | $278.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 924 | $305.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 924 | $367.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 924 | $426.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 924 | $301.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 924 | $249.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 924 | $217.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 924 | $254.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 924 | $224.5K | <0.1% | +924 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −924−100.0% | Sold out | Holders |
| Q4 2022 | 924 | $219.6K | <0.1% | +924 | New | Holders |